Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Net Margin Over TimeExpanding
Percentile Rank14
Studio
Year-over-Year Change

Net income as a percentage of revenue

Latest
-148.38%
↑ 96% vs avg
Percentile
P14
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-3772.06%
Historical baseline
PeriodValueYoY Change
TTM-148.38%+34.6%
2024-226.84%+99.4%
2023-37345.42%-
20220.00%-
20210.00%-
20200.00%-
20190.00%-
20180.00%-
20170.00%-
20160.00%-